Early diagnostics of diseases
Medical experts and scientists are increasingly joining forces to find ways of diagnosing diseases at an earlier stage. With new technologies, diagnostics will be more reliable and less expensive. These new approaches also promise to cause patients less pain and inconvenience.
Nanotechnology enables us to screen individuals for diseases, such as cancer, using just a minimal amount of body fluids. At MESA+ we are working closely with medical experts to identify so-called ‘biomarkers’ for selected diseases, to develop devices and ever smaller (bio-)sensors for analyzing those markers.